Dronedarone (Multaq) (Dronedarone (Dronedaron)) and Pitolisant (Wakix): interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Combined QT or repolarisation effects may increase cardiac risk.
Clinical significance and safety
Dronedarone (Multaq) and Pitolisant (Wakix): Combined QT or repolarisation effects may increase cardiac risk. Heart disease, a slow pulse and low potassium or magnesium can increase concern. A clinician determines whether ECG or electrolyte checks are needed. Fainting or new irregular palpitations require urgent assessment.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.